SRX1 Antibody

What is SRX1 and what is its biological function?

SRX1 (sulfiredoxin 1 homolog, also known as SRXN1) is a 14 kDa cytosolic protein that plays a crucial role in cellular response to oxidative stress . It functions primarily as an oxidoreductase, acting on sulfur groups of donors . SRX1's most well-characterized function is the reduction of hyperoxidized peroxiredoxins, thereby enabling their recycling and maintaining cellular antioxidant capacity . The protein is evolutionarily conserved across species, with homologs identified in various organisms from yeast to humans . In pathogenic fungi such as Cryptococcus neoformans, SRX1 has been identified as a critical virulence factor that contributes to the organism's ability to survive within the host environment by counteracting oxidative stress mechanisms . Beyond its peroxiredoxin-dependent functions, SRX1 has also been implicated in peroxiredoxin-independent processes, including responses to certain fungicides .

What applications can SRX1 antibodies be used for?

Based on validated research applications, SRX1 antibodies can be employed in multiple experimental techniques:

SRX1 antibodies have shown particularly robust performance in Western blot analysis of oxidative stress response pathways and in immunohistochemical examination of tissues with altered redox status, including cancer specimens .

What is the recommended protocol for SRX1 antibody in Western blot experiments?

For optimal Western blot results with SRX1 antibody, researchers should follow these methodological guidelines:

• Sample preparation: Total protein extraction from cells (e.g., A549, HepG2, U-251) or tissues (e.g., mouse liver) using standard lysis buffers containing protease inhibitors .

• Protein loading: Load 20-50 μg of total protein per lane for cell lines and 50-100 μg for tissue samples.

• Dilution ratios: Use the antibody at 1:500-1:3000 dilution, with 1:1000 being a recommended starting point for optimization .

• Positive controls: Include A549 cells or mouse liver tissue lysates as positive controls, as these have been consistently validated for SRX1 expression .

• Expected molecular weight: Probe for a band at approximately 14 kDa, which is the observed molecular weight of SRX1 protein .

• Secondary antibody selection: Use an appropriate anti-rabbit IgG secondary antibody conjugated to HRP for chemiluminescent detection .

For detailed protocol steps, follow the manufacturer's specific recommendations, which may include specialized buffer compositions or blocking conditions .

How can I optimize SRX1 antibody conditions for immunohistochemistry in different tissue types?

Successful immunohistochemical staining with SRX1 antibody requires tissue-specific optimization:

• Antigen retrieval: For most tissues, heat-induced epitope retrieval using TE buffer at pH 9.0 is recommended. For difficult samples, an alternative approach using citrate buffer at pH 6.0 may be necessary .

• Antibody dilution: Begin with a dilution range of 1:20-1:200, with 1:100 being a suitable starting point . The optimal dilution should be determined empirically for each tissue type.

• Validated tissue types: SRX1 antibody has been successfully used in human lung cancer tissue, human breast cancer tissue, and human kidney tissue, making these appropriate positive controls .

• Detection systems: Both DAB (3,3'-diaminobenzidine) and AEC (3-amino-9-ethylcarbazole) chromogens are compatible with SRX1 antibody detection.

• Counterstaining: Light hematoxylin counterstaining provides optimal nuclear contrast without obscuring cytoplasmic SRX1 staining.

It is essential to include both positive and negative controls in each IHC experiment to validate specificity and rule out non-specific binding .

What is the role of SRX1 in peroxiredoxin recycling and oxidative stress response?

SRX1 plays a critical enzymatic role in maintaining cellular antioxidant capacity through its interaction with peroxiredoxins:

• Mechanistic function: SRX1 catalyzes the ATP-dependent reduction of hyperoxidized peroxiredoxins (Prxs) that contain cysteine sulfinic acid (Cys-SO₂H), thereby restoring their peroxidase activity .

• Pathway integration: Research in Cryptococcus neoformans has demonstrated that SRX1 functions in concert with thioredoxins (Trx1 and Trx2) in the recycling of oxidized Tsa1 (a peroxiredoxin) . Immunoblot analysis revealed that both Srx1 and Trx1 are essential for this recycling process .

• Regulatory mechanisms: The High Osmolarity Glycerol (HOG) pathway is essential for transcriptional regulation of SRX1 under peroxide stress conditions . Phosphorylation of Hog1 is modulated by both low and high doses of exogenous hydrogen peroxide treatment .

• Specificity of function: Gene deletion studies have shown that SRX1 is specifically required for cells to counteract peroxide stress, but not other oxidative damaging agents . This suggests a specialized role in the cellular defense against hydrogen peroxide-induced damage.

• Pathophysiological relevance: In fungal pathogens, SRX1 contributes to virulence by enabling survival under host-imposed oxidative stress conditions . This has been confirmed through mouse infection models showing reduced virulence in SRX1-deficient strains .

How should I approach SRX1 antibody-based immunoprecipitation for protein interaction studies?

For successful immunoprecipitation experiments with SRX1 antibody, follow these methodological guidelines:

• Antibody amount: Use 0.5-4.0 μg of SRX1 antibody for every 1.0-3.0 mg of total protein lysate . Start with 2 μg per 1 mg lysate and adjust based on pull-down efficiency.

• Validated cell systems: A549 cells have been successfully used for SRX1 immunoprecipitation and serve as a reliable model system .

• Pre-clearing step: Pre-clear lysates with protein A/G beads for 1 hour at 4°C to reduce non-specific binding.

• Incubation conditions: After adding the antibody to pre-cleared lysate, incubate overnight at 4°C with gentle rotation to maximize antigen-antibody interaction.

• Washing stringency: Use progressively less stringent washing buffers to remove non-specific interactions while preserving specific SRX1 protein complexes.

• Elution considerations: For downstream mass spectrometry analysis, consider acid elution methods rather than boiling in SDS to minimize antibody contamination.

• Controls: Always include an IgG isotype control and, if available, SRX1-knockout/knockdown samples as negative controls .

For studying SRX1 interactions with peroxiredoxins or thioredoxins, consider crosslinking approaches to capture transient interactions that occur during the redox cycling process .

What are the peroxiredoxin-independent functions of SRX1?

Beyond its canonical role in peroxiredoxin recycling, SRX1 exhibits several peroxiredoxin-independent functions:

• Fungicide response: In Cryptococcus neoformans, SRX1 has been found to be required for fungicide-dependent cell swelling and growth arrest, independent of its peroxiredoxin recycling function . This suggests a role in membrane integrity or cell wall dynamics under certain stress conditions.

• Signal transduction: Emerging evidence suggests SRX1 may participate in redox-sensitive signaling pathways by directly modulating the oxidation state of signaling proteins beyond peroxiredoxins.

• Metabolic regulation: SRX1 has been implicated in regulating cellular energetics through interactions with metabolic enzymes, potentially linking redox homeostasis to metabolic adaptation.

• Stress granule association: Under certain stress conditions, SRX1 may associate with cytoplasmic stress granules, suggesting a potential role in post-transcriptional regulation during oxidative stress.

These non-canonical functions appear to be context-dependent and may vary across different cell types and organisms . Further research is needed to fully characterize these alternative functions and their physiological significance.

How can I validate the specificity of SRX1 antibody in my experimental system?

Rigorous validation of SRX1 antibody specificity is essential for reliable experimental results:

• Genetic validation: The gold standard approach utilizes SRX1 knockout/knockdown models. Multiple publications have employed this method for definitive validation . If generating such models is not feasible, consider using commercially available SRX1-deficient cell lysates.

• Antigen blocking: Pre-incubate the antibody with excess recombinant SRX1 protein before application to verify that signal loss occurs due to specific epitope binding.

• Molecular weight verification: Confirm that the detected band appears at the expected molecular weight of 14 kDa . Multiple sources confirm this observed weight matches the calculated molecular weight.

• Multi-technique confirmation: Validate findings across different techniques (e.g., WB, IHC, and IF) to ensure consistent detection patterns.

• Cross-reactivity assessment: Test the antibody against related proteins to ensure it does not cross-react with other members of the same protein family.

Commercial SRX1 antibodies undergo validation against known positive samples (A549 cells, mouse liver tissue, transfected HEK-293 cells, HepG2 cells, U-251 cells) and negative controls to ensure specificity and high affinity .

What are common technical challenges when working with SRX1 antibody and how can they be addressed?

Researchers working with SRX1 antibody may encounter several technical challenges:

• Signal variability under oxidative conditions:

  • Challenge: SRX1 levels and detection may fluctuate depending on the oxidative state of the sample.

  • Solution: Standardize sample collection timing and processing conditions. Consider using antioxidants in lysis buffers to stabilize the redox state.

• Non-specific bands in Western blot:

  • Challenge: Additional bands appearing above or below the expected 14 kDa band.

  • Solution: Increase blocking time/concentration, optimize antibody dilution (try 1:1000-1:2000), use gradient gels for better separation, and increase washing stringency .

• Weak signal in immunohistochemistry:

  • Challenge: Poor staining intensity despite appropriate positive controls.

  • Solution: Optimize antigen retrieval (try both TE buffer pH 9.0 and citrate buffer pH 6.0), reduce antibody dilution (1:20-1:50), increase incubation time, or employ signal amplification systems .

• Background in immunofluorescence:

  • Challenge: High background fluorescence masking specific signal.

  • Solution: Use fresh fixatives, extend blocking time with 5% BSA or 10% normal serum, include 0.1-0.3% Triton X-100 for better antibody penetration, and optimize antibody concentration.

• Inconsistent immunoprecipitation results:

  • Challenge: Variable pull-down efficiency between experiments.

  • Solution: Standardize lysate concentration, increase antibody amount (2-4 μg per mg of lysate), extend incubation time, and ensure proper bead washing .

How can I employ SRX1 antibody in multiplex immunofluorescence studies investigating redox signaling networks?

Multiplex immunofluorescence with SRX1 antibody allows simultaneous visualization of redox network components:

• Antibody selection: Choose SRX1 antibody that has been validated for immunofluorescence applications . Ensure it is raised in a species that allows proper combination with other primary antibodies.

• Compatible markers for co-detection:

  • Peroxiredoxins (especially Tsa1/Prx1) to visualize substrate-enzyme relationships

  • Thioredoxins (Trx1, Trx2) to examine the complete redox recycling system

  • Oxidative stress markers (8-OHdG, 4-HNE) to correlate with cellular damage

  • Subcellular compartment markers to assess SRX1 translocation under stress

• Fluorophore selection: Assign fluorophores with well-separated emission spectra to prevent bleed-through.

• Sequential staining protocol:

  • Begin with antigen retrieval optimized for SRX1 (TE buffer pH 9.0)

  • Apply primary antibodies sequentially with appropriate blocking steps

  • Use tyramide signal amplification for weak signals

  • Include spectral unmixing in analysis if using more than 4 fluorophores

• Controls and validation:

  • Single-stained controls to establish proper exposure settings

  • Fluorescence minus one (FMO) controls to set gating thresholds

  • Absorption controls to verify absence of cross-reactivity between antibodies

This approach has been successfully employed in examining oxidative stress networks in cancer tissues, where SRX1 expression patterns can be correlated with specific cellular states and microenvironmental conditions .

What methodologies can be used to study the regulation of SRX1 expression under oxidative stress conditions?

To investigate SRX1 expression regulation during oxidative stress:

• Transcriptional regulation:

  • Real-time qPCR to measure SRX1 mRNA levels following oxidative challenge

  • Chromatin immunoprecipitation (ChIP) to identify transcription factors binding to the SRX1 promoter

  • Luciferase reporter assays with wild-type and mutated SRX1 promoter constructs

  • CRISPR interference to systematically identify regulatory elements

• Post-transcriptional regulation:

  • RNA immunoprecipitation to identify RNA-binding proteins that regulate SRX1 mRNA stability

  • 3'UTR reporter assays to assess miRNA-mediated regulation

  • Polysome profiling to examine translational efficiency under stress

• Post-translational regulation:

  • Western blot with SRX1 antibody following various stress conditions and time points

  • Phospho-specific antibodies to detect modification-dependent regulation

  • Cycloheximide chase assays to determine protein stability and half-life

  • Proteasome inhibition studies to assess degradation pathways

• Pathway analysis:

  • Pharmacological inhibitors or genetic perturbation of the HOG pathway components, which has been shown to regulate SRX1 expression in fungal systems

  • Analysis of Nrf2 pathway activation, a key regulator of antioxidant response in mammalian cells

  • Measurement of SRX1 protein levels in conjunction with Hog1 phosphorylation status

The discovery that the HOG pathway is essential for transcriptional regulation of SRX1 under peroxide stress conditions provides a framework for investigating similar regulatory mechanisms in mammalian systems .

How does the specificity profile of different commercial SRX1 antibodies compare for high-throughput protein interaction studies?

When selecting SRX1 antibodies for high-throughput protein interaction studies:

• Epitope considerations:

  • Antibodies targeting different epitopes may reveal distinct interaction profiles

  • N-terminal vs. C-terminal targeting may affect detection of interaction-dependent conformational changes

  • Consider domain-specific antibodies if investigating region-specific interactions

• Cross-platform performance comparison:

• Application in high-throughput methods:

  • For techniques like PolyMap (polyclonal mapping), antibody specificity is critical for accurate protein-protein interaction profiling

  • Antibodies should be validated for minimal cross-reactivity to prevent false-positive interactions

  • For multiplexed approaches, consider using antibodies with demonstrated performance in complex sample matrices

• Considerations for integration with emerging technologies:

  • Compatibility with proximity labeling techniques (BioID, APEX)

  • Performance in microfluidic-based single-cell approaches

  • Suitability for automation and robotic handling systems

• Validation in high-throughput contexts:

  • Pilot studies with known interaction partners

  • Correlation of results with orthogonal methods

  • Assessment of reproducibility across technical and biological replicates

When implementing high-throughput interaction profiling methods like PolyMap, antibody specificity directly impacts the quality and reliability of the resulting interaction networks .

What emerging applications of SRX1 antibody show promise for advancing redox biology research?

Several innovative applications of SRX1 antibody are emerging in the field:

• Spatial proteomics: Integration of SRX1 antibody with imaging mass cytometry or multiplexed ion beam imaging to map redox enzyme localization relative to oxidative damage markers at subcellular resolution.

• Live-cell imaging: Development of non-interfering SRX1 antibody fragments (Fabs) conjugated to cell-permeable fluorophores for real-time monitoring of SRX1 dynamics during acute oxidative stress.

• Single-cell proteomics: Application of SRX1 antibody in microfluidic-based single-cell Western blotting to examine cell-to-cell variability in redox enzyme expression within heterogeneous populations.

• Extracellular vesicle (EV) characterization: Analysis of SRX1 content in EVs as potential biomarkers of cellular oxidative stress status in various pathologies.

• Antibody-based biosensors: Development of SRX1 antibody-based electrochemical or optical biosensors for continuous monitoring of SRX1 levels in experimental systems.

• High-throughput screening applications: Utilization of SRX1 antibody in automated imaging platforms for screening compounds that modulate the oxidative stress response.

• Integration with PolyMap technology: Leveraging high-throughput specificity profiling methods for mapping SRX1 interactions across diverse physiological and pathological contexts .

These emerging applications have the potential to significantly advance our understanding of redox biology and oxidative stress responses in normal physiology and disease states.